Literature DB >> 10919765

Simple and efficient method for heterologous expression of clostridial proteins.

A G Zdanovsky1, M V Zdanovskaia.   

Abstract

Many clostridial proteins are poorly produced in Escherichia coli. It has been suggested that this phenomena is due to the fact that several types of codons common in clostridial coding sequences are rarely used in E. coli and the quantities of the corresponding tRNAs in E. coli are not sufficient to ensure efficient translation of the corresponding clostridial sequences. To address this issue, we amplified three E. coli genes, ileX, argU, and leuW, in E. coli; these genes encode tRNAs that are rarely used in E. coli (the tRNAs for the ATA, AGA, and CTA codons, respectively). Our data demonstrate that amplification of ileX dramatically increased the level of production of most of the clostridial proteins tested, while amplification of argU had a moderate effect and amplification of leuW had no effect. Thus, amplification of certain tRNA genes for rare codons in E. coli improves the expression of clostridial genes in E. coli, while amplification of other tRNAs for rare codons might not be needed for improved expression. We also show that amplification of a particular tRNA gene might have different effects on the level of protein production depending on the prevalence and relative positions of the corresponding codons in the coding sequence. Finally, we describe a novel approach for improving expression of recombinant clostridial proteins that are usually expressed at a very low level in E. coli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919765      PMCID: PMC92129          DOI: 10.1128/AEM.66.8.3166-3173.2000

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  32 in total

1.  Nucleotide sequence of Clostridium botulinum C1 neurotoxin.

Authors:  D Hauser; M W Eklund; H Kurazono; T Binz; H Niemann; D M Gill; P Boquet; M R Popoff
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

2.  Relationship between protein synthesis and concentrations of charged and uncharged tRNATrp in Escherichia coli.

Authors:  M V Rojiani; H Jakubowski; E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene.

Authors:  D E Thompson; J K Brehm; J D Oultram; T J Swinfield; C C Shone; T Atkinson; J Melling; N P Minton
Journal:  Eur J Biochem       Date:  1990-04-20

4.  In vitro transcription of the supB-E tRNA operon of Escherichia coli. Characterization of transcription products.

Authors:  N Nakajima; H Ozeki; Y Shimura
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

5.  Frameshift suppression at tandem AGA and AGG codons by cloned tRNA genes: assigning a codon to argU tRNA and T4 tRNA(Arg).

Authors:  R A Spanjaard; K Chen; J R Walker; J van Duin
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

6.  Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor.

Authors:  D K Strickland; J D Ashcom; S Williams; W H Burgess; M Migliorini; W S Argraves
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  Genomic organization and physical mapping of the transfer RNA genes in Escherichia coli K12.

Authors:  Y Komine; T Adachi; H Inokuchi; H Ozeki
Journal:  J Mol Biol       Date:  1990-04-20       Impact factor: 5.469

8.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

9.  Botulinum A toxin injection as a treatment for blepharospasm.

Authors:  A B Scott; R A Kennedy; H A Stubbs
Journal:  Arch Ophthalmol       Date:  1985-03

10.  Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.

Authors:  A J Makoff; M D Oxer; M A Romanos; N F Fairweather; S Ballantine
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

View more
  9 in total

1.  Inhibition of translation by consecutive rare leucine codons in E. coli: absence of effect of varying mRNA stability.

Authors:  Ping Shu; Huacheng Dai; Wenwu Gao; Emanuel Goldman
Journal:  Gene Expr       Date:  2006

Review 2.  Engineering genes for predictable protein expression.

Authors:  Claes Gustafsson; Jeremy Minshull; Sridhar Govindarajan; Jon Ness; Alan Villalobos; Mark Welch
Journal:  Protein Expr Purif       Date:  2012-03-08       Impact factor: 1.650

3.  The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains.

Authors:  Markus Zimmer; Natasa Vukov; Siegfried Scherer; Martin J Loessner
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

4.  High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.

Authors:  Ebrahim Valipour; Mir-Latif Moosavi; Jafar Amani; Shahram Nazarian
Journal:  World J Microbiol Biotechnol       Date:  2014-01-29       Impact factor: 3.312

5.  Peptide phage display library as source for inhibitors of clostridial neurotoxins.

Authors:  A G Zdanovsky; N V Karassina; D Simpson; M V Zdanovskaia
Journal:  J Protein Chem       Date:  2001-01

6.  Improvement of cellulolytic properties of Clostridium cellulolyticum by metabolic engineering.

Authors:  Emmanuel Guedon; Mickaël Desvaux; Henri Petitdemange
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

7.  Genome of bacteriophage P1.

Authors:  Małgorzata B Łobocka; Debra J Rose; Guy Plunkett; Marek Rusin; Arkadiusz Samojedny; Hansjörg Lehnherr; Michael B Yarmolinsky; Frederick R Blattner
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

8.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Minigene-like inhibition of protein synthesis mediated by hungry codons near the start codon.

Authors:  Eva Jacinto-Loeza; Serafín Vivanco-Domínguez; Gabriel Guarneros; Javier Hernández-Sánchez
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.